Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Baxter A/S
A/S
Active
CVR 72246012
Tobaksvejen 23A, 2860
Søborg
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1984 · 41 years old
10 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Baxter A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
86M
64M
43M
21M
0M
2021: 51M
51M
2021
2022: 55M (+8% vs 2021)
55M
+8%
2022
2023: 54M (-2% vs 2022)
54M
-2%
2023
2024: 20M (-63% vs 2023)
20M
-63%
2024
2025: 69M (+245% vs 2024)
69M
+245%
2025
EBITDA
DKK millions
15M
11M
7M
4M
0M
2021: 10M
10M
2021
2022: 12M (+20% vs 2021)
12M
+20%
2022
2023: 10M (-17% vs 2022)
10M
-17%
2023
2024: 7M (-30% vs 2023)
7M
-30%
2024
2025: 4M (-43% vs 2024)
4M
-43%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
68.787
19.918
53.718
54.626
51.207
Staff expenses
-12.376
-12.497
-28.730
-30.093
-31.622
EBITDA
4.185
7.391
10.314
12.305
10.017
Depreciation & amort.
-1.672
-1.657
-4.752
-4.265
-4.331
EBIT
2.514
5.734
5.562
8.039
5.686
Net financials
1.100
2.103
1.802
238
-20
Profit before tax
3.614
7.837
7.364
8.277
5.666
Tax
1.285
1.812
1.709
1.954
1.318
Net profit
2.329
6.025
5.655
6.323
4.348
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
54.653
70.924
90.663
76.823
71.885
Equity
45.518
43.189
49.012
43.357
37.035
Long-term debt
0
0
0
0
0
Short-term debt
8.401
26.898
40.717
32.108
33.181
Total debt
8.401
26.898
40.717
32.108
33.181
Financial ratios
5-year trend
EBITDA margin
6,1 %
This company
15,8 %
Market median
This company
Market median
61% below market
2021
2025
Equity ratio
83,3 %
This company
38,2 %
Market median
This company
Market median
118% above market
2021
2025
Return on equity
5,1 %
This company
18,4 %
Market median
This company
Market median
72% below market
2021
2025
Net profit margin
3,4 %
This company
8,1 %
Market median
This company
Market median
58% below market
2021
2025
Asset turnover
1,26×
This company
1,12×
Market median
This company
Market median
12% above market
2021
2025
Debt / equity
0,20×
This company
0,62×
Market median
This company
Market median
68% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Baxter A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
